Drug News

Global Breast Implants Market Projected to Reach USD 58.2 Billion by 2035, Driven by Aesthetic Procedures and Cancer Cases

According to a recent report by Roots Analysis, the breast implants market is set to burgeon, with an estimated worth of USD 19.2 billion in 2023, poised to skyrocket to USD 58.2 billion by 2035. The forecasted growth, at a compounded annual rate of 9.67% from 2023 to 2035, is attributed to the increasing demand for cosmetic procedures, primarily for aesthetic enhancement, and the rising incidence of breast cancer globally.

The surge in the popularity of body enhancement procedures, fueled by societal beauty standards and the influence of social media, has led to a robust demand for breast implants. These procedures, considered an effective means of achieving aesthetic transformations, are witnessing heightened interest, as highlighted by the International Society of Aesthetic Plastic Surgery, which reported over 2.17 million breast augmentation procedures globally. Silicone-based breast implants, constituting 17.6% of total cosmetic surgical procedures, are particularly favored for their leak-proof properties due to high crosslinking potentials.

The prevalence of breast cancer, accounting for 12.5% of new cancer cases worldwide annually, has also contributed to the upswing in demand for breast implants. As a result, the market is witnessing ongoing innovations and the development of advanced medical aesthetic solutions, further driving its growth trajectory.

Key Insights from the Report:

1.        Market Overview:

•          Estimated market value in 2023: USD 19.2 billion

•          Projected market value by 2035: USD 58.2 billion

•          Compounded annual growth rate (CAGR): 9.67%

•          Forecast Period: 2023 – 2035

2.        Geographical Coverage:

•          North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America

3.        Market Drivers:

•          Increasing emphasis on physical appearance driven by social media and beauty standards

•          Rising cases of breast cancer contributing to higher demand

•          Ongoing technological advancements, such as stem cell implants

4.        Market Restraints:

•          Risk of immune rejection of biomedical implants

•          Side effects associated with invasive breast implantation procedures

•          Stringent regulatory compliance

5.        Growth Factors:

•          Opportunities for a robust distribution network

•          Integration of advanced technologies like augmented reality and virtual reality

•          Increasing research and development efforts for safer alternatives

Recent Developments:

•          Collplant collaboration with Stratasys for regenerative breast implants

•          Establishment Labs collaboration with Seishin Plastic and Aesthetic Surgery Clinic in Japan

•          FDA approval of MENTOR MemoryGel Boost breast implant by Mentor Worldwide LLC

As the breast implants market continues to evolve, collaborations and advancements in medical aesthetic solutions are shaping its landscape. With a focus on safety and innovation, key players are driving the industry forward, anticipating substantial growth in the coming years.


Joan David-Leonhard

Joan David Leonhard is a recent Pharm.D graduate with a strong passion for the pharmaceutical industry and a particular interest in pharmaceutical media and communication. Her brief internship experience includes roles in pharmacy where she built strong patient-pharmacist relationships and a pharmaceutical media internship where she actively contributed to drug information articles, blog posts, social media engagement, and various media projects.
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker